Kidney and urologic disease status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(97 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Organ System Project}} | {{Organ System Project}} | ||
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | ||
==Status Updates== | |||
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | |||
|+ | |||
! colspan="2" style="background:#efefef;" |Resident survival guide Progress | |||
|- | |||
|Completed | |||
|15 | |||
|- | |||
|In progress | |||
|6 | |||
|- | |||
|Remaining | |||
|3 | |||
|- | |||
! colspan="2" style="background:#efefef;" |Primary care chapter Progress | |||
|- | |||
|Completed | |||
|12 | |||
|- | |||
|In progress | |||
|6 | |||
|- | |||
|Remaining | |||
|5 | |||
|} | |||
{| border="1" cellpadding="5" cellspacing="0" align="center" | | ==Primary Care Topics== | ||
{| class="wikitable sortable" | |||
! colspan="4" |Primary care chapters | |||
! colspan="3" |Primary care resident survival guides | |||
|- | |||
!Specialty | |||
!Topic | |||
!Author | |||
!Status | |||
!Resident Survival Guide Page | |||
!Author | |||
!Status | |||
|- | |||
|Nephrology||[[Acute kidney injury]] | |||
|Farima kahe | |||
|Complete | |||
|[[Acute kidney failure resident survival guide]]||Kanwal Khmuani||Needs some review | |||
|- | |||
|Nephrology||[[Acidosis]] | |||
|Carlos | |||
|Needs review | |||
|[[Acidosis resident survival guide]]|| ||P | |||
|- | |||
|Nephrology||[[Alkalosis]] | |||
|Mydah | |||
|In progress | |||
|[[Alkalosis resident survival guide]]|| ||Needs content | |||
|- | |||
|Nephrology||[[Hyperkalemia]] | |||
|Jogeeth Singh | |||
|Complete | |||
|[[Hyperkalemia resident survival guide]]||Mahmoud||Complete | |||
|- | |||
|Nephrology||[[Hypokalemia]] | |||
|Cafer Zorkun | |||
|Needs some content | |||
|[[Hypokalemia resident survival guide]]|| ||Complete | |||
|- | |||
|Nephrology||[[Hypernatremia]] | |||
|Feham Tariq | |||
|Complete | |||
|[[Hypernatremia resident survival guide]]||Mounika (Ahmed's scholar)||Being reviewed | |||
|- | |||
|Nephrology||[[Hyponatremia]] | |||
| | |||
|Needs content | |||
|[[Hyponatremia resident survival guide]]||Priyamvada||Complete | |||
|- | |||
|Nephrology||[[Metabolic acidosis]] | |||
|Sidra Kalsoom | |||
|Needs review | |||
|[[Metabolic acidosis resident survival guide]]||Ogheneochuko||Complete | |||
|- | |||
|Nephrology||[[Metabolic alkalosis]] | |||
|Marufa Marium | |||
|Needs review | |||
|[[Metabolic alkalosis resident survival guide]]||Marufa Marium||Needs English Review | |||
|- | |||
|Nephrology||[[Respiratory acidosis]] | |||
|Nasrin | |||
|Assigned needs content | |||
|[[Respiratory acidosis resident survival guide]]||Qasim Khurshid||Needs English Review | |||
|- | |||
|Nephrology||[[Respiratory alkalosis]] | |||
| | |||
|Complete | |||
|[[Respiratory alkalosis resident survival guide]]||Rinky Agnes | |||
|Needs review | |||
|- | |||
|Nephrology||[[Nephrolithiasis]] | |||
|Amandeep Singh | |||
|Complete | |||
|[[Nephrolithiasis resident survival guide]]|| ||Complete | |||
|- | |||
|Nephrology | |||
|[[Nocturia]] | |||
|Sivakrishna Kumar, Nasrin | |||
|Needs Review | |||
|[[Nocturia resident survival guide]] | |||
|Sidra | |||
|In progress | |||
|- | |||
|Nephrology||[[Polyuria]] | |||
|Amandeep Singh | |||
|Complete | |||
|[[Polyuria resident survival guide]]||Zaida | |||
|In progress | |||
|- | |||
|Nephrology||[[Renal artery stenosis]] | |||
|Shivam Singla | |||
|Assigned | |||
|[[Renal artery stenosis resident survival guide]]||Karol||Complete | |||
|- | |||
|Nephrology | |||
|[[Hematuria]] | |||
|Sivakrishna Kumar | |||
|Needs review | |||
|[[Hematuria resident survival guide]] | |||
|Tayyaba Ali | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Dysuria]] | |||
|Nabeel | |||
|In progress | |||
|[[Dysuria resident survival guide]] | |||
|Rinky | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Flank pain]] | |||
|Samantha Salomun | |||
|In progress | |||
|[[Flank pain resident survival guide]] | |||
|Qasim Khurshid | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Urinary tract infection]] | |||
|Usama Talib | |||
|Complete | |||
|[[Urinary tract infection resident survival guide]] | |||
| | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Pyuria]] | |||
|Sadaf | |||
|Complete | |||
|[[Pyuria resident survival guide]] | |||
|Ibtisam Ashraf | |||
|Needs English Review | |||
|- | |||
|Nephrology | |||
|[[Hypertension]] | |||
|Usama Talib | |||
|Complete | |||
|[[Hypertension resident survival guide]] | |||
| | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Edema generalized|Edema]] | |||
|Mydah | |||
|Complete | |||
|[[Edema resident survival guide]] | |||
|Sara zand | |||
|In progress | |||
|- | |||
|Nephrology | |||
|[[Urinary retention]] | |||
|Luke Orazem | |||
|Assigned(Sidra Kalsoom) | |||
|[[Urinary retention resident survival guide]] | |||
|Kanwal Khmuani | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Urinary incontinence]] | |||
|Maneesha | |||
|In progress | |||
|[[Urinary incontinence resident survival guide]] | |||
|Maneesha | |||
|Complete | |||
|- | |||
|} | |||
==Status Update== | |||
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | |||
|+ | |+ | ||
! colspan="2" style="background:#efefef;" | ! colspan="2" style="background:#efefef;" |Progress | ||
|- | |- | ||
|Completed | |Completed | ||
|35 | |35 | ||
|- | |- | ||
|In progress | |In progress | ||
|4 | |4 | ||
|- | |- | ||
|Remaining | |Remaining | ||
|37 | |37 | ||
|} | |} | ||
== List of Chapters Requiring Content == | ==List of Chapters Requiring Content== | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}} | ||
! style="background: #4479BA; padding: 5px 5px;" | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}} | ||
|- | |- | ||
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | | rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | ||
Line 40: | Line 234: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Acute uric acid nephropathy | *Acute uric acid nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 49: | Line 243: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Albuminuria | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 58: | Line 252: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Balkan nephropathy | *Balkan nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 67: | Line 261: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Bartter syndrome | *Bartter syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Huda | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 76: | Line 270: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Beer potomania | *Beer potomania | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 85: | Line 279: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Boyd-Stearns syndrome | *Boyd-Stearns syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 94: | Line 288: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Branchio-oto-renal syndrome | *[[Branchio-oto-renal syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 103: | Line 297: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Continuous veno-venous hemofiltration | *Continuous veno-venous hemofiltration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 112: | Line 306: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Calix diverticulum | *Calix diverticulum | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 121: | Line 315: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Contrast-induced acute kidney injury | *Contrast-induced acute kidney injury | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 130: | Line 324: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Cholesterol emboli syndrome | *Cholesterol emboli syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Abdul | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 139: | Line 333: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Crush syndrome | *Crush syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Akash Hans | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 148: | Line 342: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* C4 glomerulopathy | *C4 glomerulopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}} | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |{{ADG}} | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 157: | Line 351: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Dent's disease | *Dent's disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 166: | Line 360: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Dialysis (LP) | *Dialysis (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 175: | Line 369: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Diuresis | *Diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 184: | Line 378: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Fibrillary immunotactoid glomerulopathy | *Fibrillary immunotactoid glomerulopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 202: | Line 396: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Hypophosphatemia | *Hypophosphatemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 211: | Line 405: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Haff disease | *Haff disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Swathi Joshi | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 220: | Line 414: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hemodialysis (SP) | *Hemodialysis (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 229: | Line 423: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hypertensive nephropathy | *Hypertensive nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | | style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | ||
Line 238: | Line 432: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Kidney transplantation | *Kidney transplantation | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 247: | Line 441: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Multicystic dysplastic kidney | *Multicystic dysplastic kidney | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 257: | Line 451: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Nephroptosis | *Nephroptosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 267: | Line 461: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Nutcracker syndrome | *Nutcracker syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 277: | Line 471: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Papillorenal syndrome | *[[Papillorenal syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 286: | Line 480: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Peritoneal dialysis (SP) | *Peritoneal dialysis (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 295: | Line 489: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Phosphate nephropathy | *Phosphate nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | ||
Line 304: | Line 498: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Pyonephrosis | *Pyonephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Harshwardan Chawla | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 313: | Line 507: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rhabdomyolysis | *Rhabdomyolysis | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 322: | Line 516: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rebound diuresis | *Rebound diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 339: | Line 533: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Renal artery stenosis | *Renal artery stenosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 349: | Line 543: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Renal papillary necrosis | *Renal papillary necrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 359: | Line 553: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Thin basement membrane disease | *Thin basement membrane disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Marufa Marium | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 397: | Line 591: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Yes | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Not | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Line 405: | Line 599: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Yes | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Not | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Line 414: | Line 608: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Yes | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Not | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Bartter syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Huda | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Line 706: | Line 900: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Yes | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Done | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
|- | |- | ||
Line 805: | Line 999: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | | style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra | | style="padding: 5px 5px; background: #F5F5F5;" |Chandra |
Latest revision as of 17:45, 25 May 2021
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System leader: Maneesha Nandimandalam, MD
Status Updates
Resident survival guide Progress | |
---|---|
Completed | 15 |
In progress | 6 |
Remaining | 3 |
Primary care chapter Progress | |
Completed | 12 |
In progress | 6 |
Remaining | 5 |
Primary Care Topics
Primary care chapters | Primary care resident survival guides | |||||
---|---|---|---|---|---|---|
Specialty | Topic | Author | Status | Resident Survival Guide Page | Author | Status |
Nephrology | Acute kidney injury | Farima kahe | Complete | Acute kidney failure resident survival guide | Kanwal Khmuani | Needs some review |
Nephrology | Acidosis | Carlos | Needs review | Acidosis resident survival guide | P | |
Nephrology | Alkalosis | Mydah | In progress | Alkalosis resident survival guide | Needs content | |
Nephrology | Hyperkalemia | Jogeeth Singh | Complete | Hyperkalemia resident survival guide | Mahmoud | Complete |
Nephrology | Hypokalemia | Cafer Zorkun | Needs some content | Hypokalemia resident survival guide | Complete | |
Nephrology | Hypernatremia | Feham Tariq | Complete | Hypernatremia resident survival guide | Mounika (Ahmed's scholar) | Being reviewed |
Nephrology | Hyponatremia | Needs content | Hyponatremia resident survival guide | Priyamvada | Complete | |
Nephrology | Metabolic acidosis | Sidra Kalsoom | Needs review | Metabolic acidosis resident survival guide | Ogheneochuko | Complete |
Nephrology | Metabolic alkalosis | Marufa Marium | Needs review | Metabolic alkalosis resident survival guide | Marufa Marium | Needs English Review |
Nephrology | Respiratory acidosis | Nasrin | Assigned needs content | Respiratory acidosis resident survival guide | Qasim Khurshid | Needs English Review |
Nephrology | Respiratory alkalosis | Complete | Respiratory alkalosis resident survival guide | Rinky Agnes | Needs review | |
Nephrology | Nephrolithiasis | Amandeep Singh | Complete | Nephrolithiasis resident survival guide | Complete | |
Nephrology | Nocturia | Sivakrishna Kumar, Nasrin | Needs Review | Nocturia resident survival guide | Sidra | In progress |
Nephrology | Polyuria | Amandeep Singh | Complete | Polyuria resident survival guide | Zaida | In progress |
Nephrology | Renal artery stenosis | Shivam Singla | Assigned | Renal artery stenosis resident survival guide | Karol | Complete |
Nephrology | Hematuria | Sivakrishna Kumar | Needs review | Hematuria resident survival guide | Tayyaba Ali | Needs English review |
Nephrology | Dysuria | Nabeel | In progress | Dysuria resident survival guide | Rinky | Complete |
Nephrology | Flank pain | Samantha Salomun | In progress | Flank pain resident survival guide | Qasim Khurshid | Needs English review |
Nephrology | Urinary tract infection | Usama Talib | Complete | Urinary tract infection resident survival guide | Complete | |
Nephrology | Pyuria | Sadaf | Complete | Pyuria resident survival guide | Ibtisam Ashraf | Needs English Review |
Nephrology | Hypertension | Usama Talib | Complete | Hypertension resident survival guide | Complete | |
Nephrology | Edema | Mydah | Complete | Edema resident survival guide | Sara zand | In progress |
Nephrology | Urinary retention | Luke Orazem | Assigned(Sidra Kalsoom) | Urinary retention resident survival guide | Kanwal Khmuani | Needs English review |
Nephrology | Urinary incontinence | Maneesha | In progress | Urinary incontinence resident survival guide | Maneesha | Complete |
Status Update
Progress | |
---|---|
Completed | 35 |
In progress | 4 |
Remaining | 37 |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | |||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Tayyaba Ali | Huda | ||||
|
|||||||
|
|||||||
Assigned | Shivam Singla | Sara Mohsin | |||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Abdul | Ahmed Elsaiey | ||||
|
Assigned | Akash Hans | Ahmed | ||||
|
Assigned | Norina Usman, M.B.B.S[1] | Aditya Ganti M.B.B.S. [2] | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Swathi Joshi | |||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
Assigned | Shivam Singla | Sara Mohsin | |||||
|
|||||||
|
Assingned | Ayesha FJ | Sogand | ||||
|
Assigned | Harshwardan Chawla | Aditya | ||||
|
Assingned | Ayesha FJ, | Sogand | ||||
|
|||||||
|
Assigned | Shakiba | Elsaiey,Ahmed | ||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
Assigned | Marufa Marium | Maneesha |
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Cardiorenal syndrome | Assigned | Dina | Huda | |||
Analgesic nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
HIV associated nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Milk-alkali syndrome | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Bartter syndrome | Assigned | Tayyaba | Huda | Yes | Not done | ||
Completed chapters
Category | Chapters | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Electrolyte imbalance (LP) | Mehdi | Yes | Done | Mehrian | ||
Hyponatremia | Saeedeh | Yes | Done | Mahshid | |||
Hypernatremia | Feham | Yes | Done | Elsaiey | |||
Hypokalemia | Rc-Aida | Yes | Done | Mahshid | |||
Hyperkalemia | Jogeet | Yes | Done | Amandeep | |||
Hypocalcemia | Krishna | Yes | Done | Hasan | |||
Hypercalcemia | Anmol | Yes | Done | Sudarshana Datta | |||
Glomerular Disease(LP) | Mehrian | Yes | Done | Farima | |||
Lupus Nephritis | Aida/ Omer | Yes | Done | Iqra | |||
Rapidly progressive glomerulonephritis | Nazia / Jogeet | Yes | Done | Aditya | |||
Membranous glomerulonephritis | Sunny/ Seyd | Yes | Done | Amandeep | |||
Membranoproliferative glomerulonephritis | rc Arash | Yes | Done | Aditya | |||
IgA nephropathy | Dildar | Yes | Done | Mehrian | |||
Goodpasture syndrome | Akshun | Yes | Done | Farima | |||
Amyloidosis (LP) | Shamila | Yes | Done | Mehrian | |||
Primary amyloidosis | |||||||
Secondary amyloidosis | |||||||
Familial amyloidosis | |||||||
Wild-type(senile) amyloidosis | |||||||
Cardiac amyloidosis | |||||||
Beta-2 microglobulin related amyloidosis | |||||||
Gelsolin related amyloidosis | |||||||
C3 glomerulopathy | Vindhya | Yes | Done | ||||
Bladder cancer | Farima Kahe | Yes | Done | ||||
Hydronephrosis | Chandra | Yes | Done | Aditya | |||
Kidney stone | Amandeep | Yes | Done | Aditya | |||
Polycystic kidney disease | Khurram | Yes | Done | Anmol | |||
Nephritic syndrome | Dildar | Yes | Done | Mehrian | |||
Nephrotic syndrome | Mehrian | Yes | Done | Sadaf | |||
Post-streptococcal glomerulonephritis | Manpreet | Yes | Done | Mehrian | |||
Renal cell carcinoma | Farima | Yes | Done | Anmol | |||
Renal osteodystrophy | |||||||
Renal tubular acidosis | Aditya | Yes | Done | Sargun | |||
Renal vein thrombosis | Saeedeh | Yes | Done | Mehdi | |||
Wilms' tumor | Sargun | Yes | Done | Farima |